Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6432 USD | -2.55% | +0.28% | -13.73% |
04-04 | North American Morning Briefing : Focus Turns to -2- | DJ |
04-04 | Traws Pharma, Inc. Announces Chief Executive Office Changes | CI |
Business Summary
Number of employees: 18
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Oncology Therapeutics
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | 0.00% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | 0.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steven Fruchtman
PSD | President | 73 | 15-01-18 |
Mark Guerin
DFI | Director of Finance/CFO | 55 | 13-08-31 |
Meena Arora
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-23 |
Victor Moyo
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-23 |
Matthew Parris
CTO | Chief Tech/Sci/R&D Officer | - | 18-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James Marino
BRD | Director/Board Member | 74 | 15-06-30 |
Jack Stover
BRD | Director/Board Member | 69 | 16-05-22 |
Mary Shoemaker
BRD | Director/Board Member | 63 | 20-03-31 |
Steven Fruchtman
PSD | President | 73 | 15-01-18 |
Trafford Clarke
BRD | Director/Board Member | 66 | 22-12-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 25,301,009 | 20,518,488 ( 81.10 %) | 0 | 81.10 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.73% | 13.92M | |
+0.28% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.88% | 24.63B | |
-24.41% | 18.2B | |
+26.81% | 12.01B | |
-3.17% | 11.76B | |
+10.51% | 10.4B | |
-1.33% | 9.94B |
- Stock Market
- Equities
- TRAW Stock
- Company Traws Pharma, Inc.